Skip to main content
    G

    GE HealthCare Technologies Inc. (GEHC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $82.96
    -0.06 (-0.07%)

    Market Cap: $37.54B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    GE HealthCare Technologies Inc. (GEHC) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    GE HealthCare Technologies (GEHC) trades at 16.9x trailing earnings and 1.7x sales. Its forward P/E is 15.0x. The median P/E across 11 similar companies is 21.9x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 12.7% higher over the next year. Its free cash flow yield is 5.0%.

    MultipleValue
    P/E (trailing)16.9x
    Forward P/E15.0x
    Price to sales1.7x
    Price to book3.2x
    EV/EBITDA11.6x
    Price to FCF19.9x
    EV/FCF23.6x
    PEG2.2
    FCF yield5.0%
    As of Nov 17, 2026

    Valuation History

    Over the 3 year ends shown, its P/E ranged from 17.0x in 2024 to 19.6x in 2023.

    Year endPriceP/EP/SP/B
    2025$82.0217.9x1.8x3.6x
    2024$78.1817.0x1.8x4.2x
    2023$77.3219.6x1.8x5.0x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About GEHC

    What is GEHC's forward P/E ratio?

    GE HealthCare Technologies has a forward P/E ratio of 15.0x.

    Is GEHC stock overvalued?

    GNG's valuation label for GEHC is Undervalued. Its P/E of 16.9x compares with a median of 21.9x across 11 similar companies.

    What is GEHC's price to sales ratio?

    GE HealthCare Technologies has a price to sales ratio of 1.7x.

    What is GEHC's PEG ratio?

    GE HealthCare Technologies has a PEG ratio of 2.2.